Furthermore, EGFR has been demonstrated to modulate glucose level in cancer cells by regulating sodium/glucose cotransporter 1 (SGLT1) independent of receptor tyrosine kinase activities [29]. The gene discussed is SLC5A1; the disease is cancer.